On April 23, 2024, the Federal Trade Commission (FTC) adopted a final rule that effectively prohibits the use of almost all noncompete clauses. That same day, the first litigation challenging the rule was filed. In this webinar, the speakers will cover what the final rule means for employers, the challenges the rule faces, and what employers should do next.

The opioid crisis in the United States costs tens of thousands of lives per year—and some of the victims overdose at work. Naloxone (Narcan and RiVive are two available versions) can reverse the effects of opioids and save lives, and employers are increasingly considering stocking the product at work. The FDA’s recent approval of nonprescription over-the-counter naloxone nasal sprays makes the life-saving drug more accessible to employers that want to have them on hand in case of an emergency. This multistate webinar will focus on individual state laws and requirements as well as address frequently asked questions and best practices for large and small employers alike.